Ovarian Reserve Biomarkers Not Indicative of Reduced Fertility

Share this content:
Findings do not support the use of urinary or blood follicle-stimulating hormone tests to assess natural fertility.
Findings do not support the use of urinary or blood follicle-stimulating hormone tests to assess natural fertility.

HealthDay News — Biomarkers indicating diminished ovarian reserve versus normal ovarian reserve are not associated with reduced fertility among women aged 30 to 44 years without a history of infertility who have been trying to conceive for 3 months or less, according to a study published online in the Journal of the American Medical Association.

Anne Z. Steiner, MD, MPH, from the University of North Carolina in Chapel Hill, and colleagues conducted a prospective time-to-pregnancy cohort study involving 750 women aged 30 to 44 years without a history of infertility who had been trying to conceive for 3 months or less.

The researchers found that the predicted probability of conceiving was not significantly lower for women with low antimüllerian hormone values compared to women with normal values by 6 cycles of attempt (65% vs 62%) or by 12 cycles of attempt (84% vs 75%) after adjustment for confounding variables. The predicted probability of conceiving was not significantly different for women with high serum follicle-stimulating hormone versus women with normal values after 6 cycles of attempt (63% vs 62%) or after 12 cycles of attempt (82% vs 75%); similar results were seen for high urinary follicle-stimulating hormone values.

"These findings do not support the use of urinary or blood follicle-stimulating hormone tests or antimüllerian hormone levels to assess natural fertility for women with these characteristics," the authors write.

Disclosures: One author disclosed financial ties to the pharmaceutical industry.

Reference

  1. Steiner AZ, Pritchard D, Stanczyk FZ, et al. Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA. 2017;318(14):1367-1376. doi:10.1001/jama.2017.14588
  2. Santoro N. Using antimüllerian hormone to predict fertility. JAMA. 2017;318(14):133-1334. doi:10.10001/jama.2017.14954
You must be a registered member of Endocrinology Advisor to post a comment.

Sign Up for Free e-Newsletters

CME Focus